Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


18.12.2017

1 Ann Afr Med
1 Anticancer Res
1 Arch Pathol Lab Med
2 BMC Cancer
1 BMC Public Health
1 Cancer Res
1 Cell Death Dis
1 Clin Lab
1 Clin Transl Oncol
1 Drug Deliv
1 Eur J Nucl Med Mol Imaging
3 Eur Rev Med Pharmacol Sci
1 Gynecol Oncol
1 Gynecol Oncol Rep
1 Hawaii J Med Public Health
1 Int J Cancer
2 J Cancer Res Ther
2 J Cell Biochem
1 J Glob Oncol
1 J Virol
1 Lancet Oncol
1 Med J Aust
1 Onco Targets Ther
1 Oncol Res
5 Oncotarget
2 PLoS One
1 Prev Med
1 Radiat Oncol J
2 Sci Rep
1 Sex Transm Dis
3 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Afr Med

  1. BAKARI F, Abdul MA, Ahmed SA
    The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital.
    Ann Afr Med. 2017;16:74-80.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. NIIBE Y, Onda T, Matsuo K, Inoue Y, et al
    Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results.
    Anticancer Res. 2017;37:6983-6988.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  3. PIROG EC
    Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus-Positive and Human Papillomavirus-Negative Tumors.
    Arch Pathol Lab Med. 2017;141:1653-1667.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. OBRZUT B, Kusy M, Semczuk A, Obrzut M, et al
    Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods.
    BMC Cancer. 2017;17:840.
    PubMed     Text format     Abstract available

  5. MOMANY MC, Martinez-Gutierrez J, Soto M, Capurro D, et al
    Development of mobile technologies for the prevention of cervical cancer in Santiago, Chile study protocol: a randomized controlled trial.
    BMC Cancer. 2017;17:847.
    PubMed     Text format     Abstract available


    BMC Public Health

  6. MSYAMBOZA KP, Mwagomba BM, Valle M, Chiumia H, et al
    Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    BMC Public Health. 2017;17:599.
    PubMed     Text format     Abstract available


    Cancer Res

  7. SHANG C, Wang W, Liao Y, Chen Y, et al
    LNMICC promotes nodal metastasis of cervical cancer by reprogramming fatty acid metabolism.
    Cancer Res. 2017 Dec 11. pii: 0008-5472.CAN-17-2356.
    PubMed     Text format     Abstract available


    Cell Death Dis

  8. WEI WF, Zhou CF, Wu XG, He LN, et al
    MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2.
    Cell Death Dis. 2017;8:3220.
    PubMed     Text format     Abstract available


    Clin Lab

  9. MA B, Fang J, Wang Y, He H, et al
    Isothermal Method of a Recombinase Polymerase Amplification Assay for the Detection of Most Common High-Risk Human Papillomavirus Type 16 and Type 18 DNA.
    Clin Lab. 2017;63:27-38.
    PubMed     Text format     Abstract available


    Clin Transl Oncol

  10. GODOY-ORTIZ A, Plata Y, Alcaide J, Galeote A, et al
    Bevacizumab for recurrent, persistent or advanced cervical cancer: reproducibility of GOG 240 study results in "real world" patients.
    Clin Transl Oncol. 2017 Dec 8. pii: 10.1007/s12094-017-1808.
    PubMed     Text format     Abstract available


    Drug Deliv

  11. XU S, Tang YY, Yu YX, Yun Q, et al
    Novel composite drug delivery system as a novel radio sensitizer for the local treatment of cervical carcinoma.
    Drug Deliv. 2017;24:1139-1147.
    PubMed     Text format     Abstract available


    Eur J Nucl Med Mol Imaging

  12. LUCIA F, Visvikis D, Desseroit MC, Miranda O, et al
    Prediction of outcome using pretreatment (18)F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.
    Eur J Nucl Med Mol Imaging. 2017 Dec 9. pii: 10.1007/s00259-017-3898.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  13. HU YC, Wang AM, Lu JK, Cen R, et al
    Long noncoding RNA HOXD-AS1 regulates proliferation of cervical cancer cells by activating Ras/ERK signaling pathway.
    Eur Rev Med Pharmacol Sci. 2017;21:5049-5055.
    PubMed     Text format     Abstract available

  14. ZHAO LP, Li RH, Han DM, Zhang XQ, et al
    Independent prognostic Factor of low-expressed LncRNA ZNF667-AS1 for cervical cancer and inhibitory function on the proliferation of cervical cancer.
    Eur Rev Med Pharmacol Sci. 2017;21:5353-5360.
    PubMed     Text format     Abstract available

  15. HUA FF, Liu SS, Zhu LH, Wang YH, et al
    MiRNA-338-3p regulates cervical cancer cells proliferation by targeting MACC1 through MAPK signaling pathway.
    Eur Rev Med Pharmacol Sci. 2017;21:5342-5352.
    PubMed     Text format     Abstract available


    Gynecol Oncol

  16. BIZZARRI N, Ghirardi V, Kucukmetin A
    Indocyanine green-assisted parametrial dissection during type C1 radical hysterectomy after sentinel lymph node biopsy in early stage cervical cancer.
    Gynecol Oncol. 2017 Dec 6. pii: S0090-8258(17)31496.
    PubMed     Text format     Abstract available


    Gynecol Oncol Rep

  17. ZAMORANO AS, Wan L, Powell MA, Massad LS, et al
    Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits.
    Gynecol Oncol Rep. 2017;22:48-51.
    PubMed     Text format     Abstract available


    Hawaii J Med Public Health

  18. TUTII IM, Roseveare C, Viney K, Cash HL, et al
    Breast and Cervical Cancer Screening in Palau: Have We Improved Early Detection and Survival?
    Hawaii J Med Public Health. 2017;76:337-343.
    PubMed     Text format     Abstract available


    Int J Cancer

  19. GULTEKIN M, Zayifoglu Karaca M, Kucukyildiz I, Dundar S, et al
    Initial results of population based cervical cancer screening program using hpv testing in one million turkish women.
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31212.
    PubMed     Text format     Abstract available


    J Cancer Res Ther

  20. LI F, Wu Y, Kong W, Wang J, et al
    Clinical efficacy of preoperative vaginal intracavitary irradiation for Stage Ib2 and IIa cervical cancer.
    J Cancer Res Ther. 2017;13:796-800.
    PubMed     Text format     Abstract available

  21. CAO W, Peng T, Zhou Y
    Long noncoding RNA activated by transforming growth factor-beta promotes cancer development and is a prognostic marker in cervical cancer.
    J Cancer Res Ther. 2017;13:801-806.
    PubMed     Text format     Abstract available


    J Cell Biochem

  22. TENG P, Jiao Y, Hao M, Tang X, et al
    microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.
    J Cell Biochem. 2017 Dec 13. doi: 10.1002/jcb.26585.
    PubMed     Text format     Abstract available

  23. LIU P, Ma S, Liu H, Han H, et al
    HCFU inhibits cervical cancer cells growth and metastasis by inactivating Wnt/beta-catenin pathway.
    J Cell Biochem. 2017 Dec 12. doi: 10.1002/jcb.26570.
    PubMed     Text format     Abstract available


    J Glob Oncol

  24. NARTEY Y, Hill PC, Amo-Antwi K, Nyarko KM, et al
    Cervical Cancer in the Greater Accra and Ashanti Regions of Ghana.
    J Glob Oncol. 2017;3:782-790.
    PubMed     Text format     Abstract available


    J Virol

  25. HONG S, Cheng S, Songock W, Bodily J, et al
    Suppression of MicroRNA 424 Levels by Human Papillomaviruses Is Necessary for Differentiation-Dependent Genome Amplification.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    Lancet Oncol

  26. ARBYN M, Redman CWE, Verdoodt F, Kyrgiou M, et al
    Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis.
    Lancet Oncol. 2017;18:1665-1679.
    PubMed     Text format     Abstract available


    Med J Aust

  27. WHOP LJ, Baade PD, Brotherton JM, Canfell K, et al
    Time to clinical investigation for Indigenous and non-Indigenous Queensland women after a high grade abnormal Pap smear, 2000-2009.
    Med J Aust. 2017;206:73-77.
    PubMed     Text format     Abstract available


    Onco Targets Ther

  28. LI H, Sun G, Liu C, Wang J, et al
    PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer.
    Onco Targets Ther. 2017;10:5685-5694.
    PubMed     Text format     Abstract available


    Oncol Res

  29. LV L, Wang X
    MicroRNA-296 targets specificity protein 1 to suppress cell proliferation and invasion in cervical cancer.
    Oncol Res. 2017 Dec 14. doi: 10.3727/096504017X15132494420120.
    PubMed     Text format     Abstract available


    Oncotarget

  30. CHI S, Shen L, Hua T, Liu S, et al
    Correction: Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis.
    Oncotarget. 2017;8:100957.
    PubMed     Text format     Abstract available

  31. LI L, Hou Y, Yu J, Lu Y, et al
    Synergism of ursolic acid and cisplatin promotes apoptosis and enhances growth inhibition of cervical cancer cells via suppressing NF-kappaB p65.
    Oncotarget. 2017;8:97416-97427.
    PubMed     Text format     Abstract available

  32. WANG X, Li Z, Kong B, Song C, et al
    Reduced m(6)A mRNA methylation is correlated with the progression of human cervical cancer.
    Oncotarget. 2017;8:98918-98930.
    PubMed     Text format     Abstract available

  33. CHO MJ, Lee JY, Shin MG, Kim HJ, et al
    TSC-22 inhibits CSF-1R function and induces apoptosis in cervical cancer.
    Oncotarget. 2017;8:97990-98003.
    PubMed     Text format     Abstract available

  34. SONG F, Wang G, Ma Z, Ma Y, et al
    Silencing of BAG3 inhibits the epithelial-mesenchymal transition in human cervical cancer.
    Oncotarget. 2017;8:95392-95400.
    PubMed     Text format     Abstract available


    PLoS One

  35. ROIK EE, Sharashova EE, Nieboer E, Kharkova OA, et al
    Knowledge about human papillomavirus and prevention of cervical cancer among women of Arkhangelsk, Northwest Russia.
    PLoS One. 2017;12:e0189534.
    PubMed     Text format     Abstract available

  36. ZHOU Z, Li W, Zhang F, Hu K, et al
    The value of squamous cell carcinoma antigen (SCCa) to determine the lymph nodal metastasis in cervical cancer: A meta-analysis and literature review.
    PLoS One. 2017;12:e0186165.
    PubMed     Text format     Abstract available


    Prev Med

  37. LANDY R, Cheung LC, Schiffman M, Gage JC, et al
    Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.
    Prev Med. 2017 Dec 6. pii: S0091-7435(17)30482.
    PubMed     Text format     Abstract available


    Radiat Oncol J

  38. JUNG W, Park KR, Lee KJ, Kim K, et al
    Value of imaging study in predicting pelvic lymph node metastases of uterine cervical cancer.
    Radiat Oncol J. 2017 Dec 15. pii: roj.2017.00206. doi: 10.3857/roj.2017.00206.
    PubMed     Text format     Abstract available


    Sci Rep

  39. MORINA D, de Sanjose S, Diaz M
    Impact of model calibration on cost-effectiveness analysis of cervical cancer prevention.
    Sci Rep. 2017;7:17208.
    PubMed     Text format     Abstract available

  40. ADURTHI S, Kumar MM, Vinodkumar HS, Mukherjee G, et al
    Oestrogen Receptor-alpha binds the FOXP3 promoter and modulates regulatory T-cell function in human cervical cancer.
    Sci Rep. 2017;7:17289.
    PubMed     Text format     Abstract available


    Sex Transm Dis

  41. HAIDARI LA, Brown ST, Constenla D, Zenkov E, et al
    Geospatial Planning and the Resulting Economic Impact of Human Papillomavirus Vaccine Introduction in Mozambique.
    Sex Transm Dis. 2017;44:222-226.
    PubMed     Text format     Abstract available


    Vaccine

  42. VENTURAS C, Umeh K
    Health professional feedback on HPV vaccination roll-out in a developing country.
    Vaccine. 2017 Mar 10. pii: S0264-410X(17)30265.
    PubMed     Text format     Abstract available

  43. BERENSON AB, Hirth JM, Fuchs EL
    US medical students' willingness to offer the HPV vaccine by vaccination status.
    Vaccine. 2017 Feb 1. pii: S0264-410X(17)30077.
    PubMed     Text format     Abstract available

  44. ESQUERRE M, Momot M, Goubier A, Gonindard C, et al
    GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth.
    Vaccine. 2017 Feb 10. pii: S0264-410X(17)30154.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: